Pyxis Oncology (PYXS) Total Current Liabilities (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Total Current Liabilities data on file, last reported at $21.1 million in Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $21.1 million, up 19.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.1 million (up 19.52% YoY), and the FY2025 annual result was $21.1 million, up 19.52% from the prior year.
• Total Current Liabilities grew to $21.1 million in Q4 2025 per PYXS's latest filing, from $19.4 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $31.6 million in Q4 2022 and troughed at $9.2 million in Q2 2023.
• A 5-year average of $18.7 million and a median of $18.2 million in 2021 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2021 and 2023: Total Current Liabilities jumped 407.13% in 2021, then tumbled 39.54% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $18.7 million in 2021, then surged by 69.09% to $31.6 million in 2022, then decreased by 18.57% to $25.8 million in 2023, then slumped by 31.36% to $17.7 million in 2024, then grew by 19.52% to $21.1 million in 2025.
• Business Quant data shows PYXS's Total Current Liabilities at $21.1 million in Q4 2025, $19.4 million in Q3 2025, and $17.7 million in Q2 2025.